Expectations were built up for data. Simple as that. Don't know why it keeps happening. Twice now to be generous. Keep in mind though, Lympro V1 still has stellar numbers. They could launch on that alone. V2 will be better. Get in with GC!!!!
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links